"The Technical Advisory Group has determined that the Covaxin vaccine meets WHO standards for protection against COVID-19, that the benefit of the vaccine far outweighs risks and the vaccine can be used," WHO said in a tweet. The emergency use listing would allow Bharat to ship the vaccine to countries that rely on WHO guidance for their regulatory decisions. Covaxin is the seventh to win WHO backing following two mRNA shots by Pfizer/BioNTech and Moderna, adenovirus vector vaccines developed by AstraZeneca and Johnson & Johnson, and China's inactivated vaccines from Sinovac Biotech and Sinopharm. The nod also mean that the shot may be accepted as a valid vaccine for millions of Indians who have received it and want to travel nL4N2RM0WR outside the country. Oman last week and Australia on Monday said they will recognise Covaxin as a valid vaccine for travellers.

Source: bd News24 November 04, 2021 01:00 UTC